(Q51571771)

7 April 2018

title

Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment. (English)

1 reference

7 April 2018

0 references

1 reference

3

R A DeFronzo

1 reference

7 April 2018

author name string

G B Kudolo

series ordinal

1

1 reference

7 April 2018

P Bressler

series ordinal

2

1 reference

7 April 2018

publication date

1 November 1997

1 reference

7 April 2018

Journal of lipid mediators and cell signalling

published in

1 reference

7 April 2018

volume

17

1 reference

7 April 2018

issue

2

1 reference

7 April 2018

page(s)

97-113

1 reference

7 April 2018

Insulin resistance in microalbuminuric hypertension. Sites and mechanisms.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Acute effects of intratracheal administration of platelet-activating factor in baboons.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Plasma platelet-activating factor degradation in patients with severe coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Interactions of plasma lipoproteins with endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Chronic hyperinsulinemia inhibits platelet-activating factor (PAF) biosynthesis in the rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Cholesterol-lowering therapy may retard the progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Glomerular platelet-activating factor levels and origin in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Cardiovascular effects of antihypertensive polar and neutral renomedullary lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Impaired insulin action on skeletal muscle metabolism in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

The role of platelet-activating factor (PAF) in experimental glomerular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Intraglomerular platelet aggregation and experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

The natural history of impaired glucose tolerance in the Pima Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Hypersensitivity of diabetic human platelets to platelet activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

Altered platelet functions in non-insulin-dependent diabetes mellitus (NIDDM).

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0929-7855%2897%2900023-0

7 January 2021

10.1016/S0929-7855(97)00023-0

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018